Ethyl Biscoumacetate
Also known as: Ethyl dicoumarol, Pelentan, Tromexan
Ethyl biscoumacetate is an orally administered coumarin anticoagulant with actions similar to those of warfarin . It has been used in the management of thromboembolic disorders.
Primary Characteristics
Ethyl Biscoumacetate is also known as Ethyl dicoumarol, Pelentan, Tromexan.
Molecular Weight: 408.4 · Non-proprietary name: Ethyl Biscoumacetate.
Pharmacokinetics
Elimination: plasma half-life is 0.66 hrs.
Advertisement
Indications
Ethyl Biscoumacetate is primarily indicated in conditions like Pulmonary embolism, Thrombo-embolic complications, Venous thromboembolic disease.
Contraindications
Ethyl Biscoumacetate is contraindicated in conditions like Myocardial infarction, Liver diseases, Postpartum, Hypersensitivity, Pregnancy, Bleeding, Kidney disease, Breast feeding, Duodenal ulcer.
Dosage
Ethyl Biscoumacetate's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 300 mg | 300 mg | — | Oral | |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Ethyl Biscoumacetate in overdosage may give rise to further complications which include Increased blood Clotting time, Prolonged bleeding.
Ethyl Biscoumacetate produces potentially life-threatening effects which include Severe, Hoemmorage. Careful monitoring is needed with proper medical management.
The signs and symptoms that are produced after acute overdosage of Ethyl Biscoumacetate are Increase bleeding.
Ethyl Biscoumacetate is known to cause more or less tolerable side effects which are usually transient. These include Allergic reactions, Diarrhea, Fever.
Warnings / Precautions
Available Brands
None recorded.
Drug Classification
- 1.10.2 — Anticoagulants/Platelet deaggregators